Enfortumab vedotin-ejfv Antibody
Enfortumab vedotin-ejfv (Padcev) is an antibody-drug conjugate (ADC) targeting Nectin-4 for research use. It demonstrates anti-tumor activity in preclinical models of urothelial carcinoma and is applied in both in vitro cell-based assays and in vivo xenograft studies to investigate its mechanism and efficacy.
Product Specifications
Product Name Alternative
ADCs, AntibodyDrugConjugates, AntibodyDrug Conjugates (ADCs), Antibody-Drug Conjugates, AntibodyDrugConjugates (ADCs)
Target
Nectin-4, Antibody-Drug Conjugates (ADCs)
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
8.5 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
143.9 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Epstein-Barr Virus (LMP-1) (CS4), CF488A conjugate, 0.1mg/mL
PMEPA1 / TMEPAI (Tumor Suppressor Oncoprotein) (PMEPA1/2697), CF640R conjugate, 0.1mg/mL
CD50 / ICAM3 (CG106), CF405S conjugate, 0.1mg/mL
